Delivery Order SPE2DB20D2014-SPE2DB25FA16T

Award Date 10/22/24
Potential Completion Date 10/23/24
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract has a ceiling value of $8,599.91 and is structured as a firm fixed-price delivery order. It does not have a set-aside designation....
The federal contract award is for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, with a ceiling value of $6,220.56. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. This is a delivery order contract with a firm fixed price pricing type, with an ultimate completion date of June 17, 2025. The contract is not set-aside and...
This federal contract award with the Defense Logistics Agency (DLA) is for the delivery of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract, valued at $4,743.48, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to...
The federal contract award is for the delivery of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML to the Defense Logistics Agency (DLA). The firm fixed-price contract, valued at $2,203.25, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 5, 2024 and was awarded on January 4, 2024. This contract is not designated as a set-aside....
This federal contract award is for the delivery of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML to the Defense Logistics Agency (DLA). The contract, valued at $3,650.34, is a delivery order issued under a larger Indefinite Delivery Contract (IDC) held by the prime contractor, Amerisourcebergen Drug Corp, with the DLA Troop Support Medical. The IDC, worth $999,999,999, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products...
This federal contract award is for the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $8,595.27 firm fixed price delivery order contract has a completion date of June 26, 2025. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract...
This federal contract award is for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The $7,425.59 fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML to the Defense Logistics Agency (DLA). The award, valued at $1,804.52, was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of May 17, 2024. Amerisourcebergen Drug...
This federal contract award is for the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $6,649.41. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of June 17, 2025. The contract is not set aside for any...
This federal contract award is for the delivery of the pharmaceutical product "WEGOVY 1 MG/0.5 ML PEN 0.5ML" to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is a Delivery Order with a Firm Fixed Price of $1,214.15 and has an ultimate completion date of February 21, 2024. Amerisourcebergen...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA16T
    Delivery Order

This federal contract award is for the supply of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, in the amount of $3,166.56. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 1/22/25, 12:57 AM